Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Start Training Now
IAPAM Logo
Aesthetic Medicine Symposium - November 14-16 in Scottsdale, AZ! Secure Your Spot

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

IAPAM Logo
Aesthetic Medicine Symposium — Nov 14–16, Scottsdale, AZ   Secure Your Spot →
Home » Medical Weight Management Library  » Saxenda® vs. Wegovy®: Which is Better for Weight Loss?

Saxenda® vs. Wegovy®: Which is Better for Weight Loss?

The prevalence of obesity has given rise to a range of pharmacological interventions aimed at weight management. Among these, Saxenda® and Wegovy® have emerged as notable treatments, each backed by substantial clinical research. Although both medications share similarities in their classification as GLP-1 receptor agonists, they possess distinct characteristics that could influence their effectiveness and suitability for different individuals.

Saxenda® vs. Wegovy

Table of Contents

How Do Saxenda® and Wegovy® Work?

Saxenda® is a GLP-1 receptor agonist that mimics the GLP-1 hormone, which is naturally produced in the intestines in response to food. GLP-1 plays a crucial role in regulating appetite and insulin secretion. By activating the GLP-1 receptors, Saxenda® helps to:
– Increase insulin secretion in response to meals
– Slow gastric emptying
– Reduce appetite and caloric intake

Wegovy® also falls under the GLP-1 receptor agonist category but is structurally different from Saxenda®. As a synthetic version of GLP-1, it activates the same receptors to:
– Enhance insulin secretion
– Delay gastric emptying
– Suppress appetite

The key difference lies in its potency and pharmacokinetics. Wegovy® has a longer half-life than Saxenda®, allowing for less frequent dosing.

So is Saxenda® or Wegovy® better for weight loss?

Clinical trials have demonstrated that Saxenda® can lead to significant weight loss in individuals with obesity. On average, patients may experience a weight reduction of approximately 5-10% over the course of a year. The variation in effectiveness is often influenced by lifestyle changes, adherence to the medication, and individual metabolic responses.

Wegovy® has shown even more impressive results in clinical studies. Patients using Wegovy® have reported an average weight loss of up to 15% or more over the same period. The higher efficacy of Wegovy® can be attributed to its increased potency and longer duration of action, which sustains therapeutic effects over a more extended period.

Reserve Your Spot
AN IAPAM TRAINING | September 18-21, 2026 | Limited Time Offer: Save 15% on registration
Gain the confidence you need — build the lifestyle & practice you deserve

Includes hands-on Botox® injection training on live models in a clean clinic setting

33.5 CMES | 4-Day Hands-On | Scottsdale, Arizona | Save up to $3,605
AN IAPAM TRAINING | September 18-21 | Save 15% on Registration
Gain the confidence you need — build the lifestyle and practice you deserve
33.5 CMEs | 4-Day Hands-On | Scottsdale, Arizona | Save up to $3,605
Reserve Your Spot

How are Saxenda® and Wegovy® administered?

Saxenda® is administered as a once-daily subcutaneous injection. The treatment begins with a lower dose of 0.6 mg and gradually increases to a maintenance dose of 3 mg. The titration over several weeks helps to minimize gastrointestinal side effects and allows the body to adapt to the medication.

Wegovy® is administered less frequently, with a recommended dose of once a week. The treatment starts at a lower dose of 0.25 mg and gradually increases to a maintenance dose of 2.4 mg. The weekly administration is a significant advantage for patients seeking a more convenient dosing schedule.

Are there Side Effects for Saxenda® and Wegovy®?

The most common side effects of Saxenda® include nausea, vomiting, diarrhea, and constipation. These symptoms generally occur at the beginning of the treatment and tend to subside as the body adjusts. More severe but rare side effects can include pancreatitis, gallbladder disease, and renal impairment.

Wegovy® shares similar gastrointestinal side effects, such as nausea, diarrhea,and constipation. Due to its higher potency, some users may experience these side effects more intensely, but they typically wane over time. As with Saxenda®, severe adverse effects like pancreatitis can occur and require medical evaluation.

IAPAM Learning Lab

Your next clinical skill should not have to wait for your next free weekend.

Patients are already asking about GLP-1s, injectables, PRP, lasers, and aesthetic treatments. Build the knowledge to have better clinical conversations now—on a schedule that works around your practice.

✓Start with the clinical topic your patients are asking about today.
✓Learn at your pace, then revisit the material as you integrate new services.
✓Explore focused training in medical weight management and aesthetic medicine.
Explore On-Demand Training →

Need hands-on BOTOX® training instead? Explore IAPAM’s Botox training options →

Saxenda® and Wegovy®: Benefits and Considerations

Saxenda®

Pros:
– Established efficacy in weight management
– Daily dosing provides consistent therapeutic levels
– Proven to improve glycemic control in diabetic patients

Cons:
– Daily injections may be inconvenient for some
– Higher incidence of gastrointestinal side effects
– Requires regular monitoring and gradual dose escalation

Wegovy®

Pros:
– Higher average weight loss compared to Saxenda®
– Once-weekly dosing increases convenience and adherence
– Potent and long-acting formulation

Cons:
– More intense initial gastrointestinal side effects for some
– Still relatively new, and long-term safety data is evolving
– Higher cost and potential insurance barriers

Real-World Application of Saxenda® and Wegovy®

In clinical practice, the choice between Saxenda® and Wegovy® often depends on patient-specific factors, including their medical history, lifestyle, and preferences. For some, the convenience of a weekly injection with Wegovy® is a significant advantage. For others, the familiarity and well-documented efficacy of Saxenda® might make it the preferred option.

Additionally, both medications are often considered part of a broader weight management program that includes lifestyle interventions such as diet, exercise, and behavioral therapy. The effectiveness of these drugs is markedly enhanced when combined with these lifestyle modifications.

Wegovy® vs Saxenda®: Conclusion

Saxenda® and Wegovy® both offer effective pharmacological options for weight management, each with its unique advantages and considerations. Saxenda® provides a well-established treatment with daily dosing, while Wegovy® offers a more convenient weekly administration with potentially greater efficacy. The decision between the two should be personalized, taking into account the patient’s specific needs, medical conditions, and lifestyle.

Consultation with healthcare providers is crucial in customizing treatment plans to optimize weight management and improve overall health outcomes. As obesity continues to be a significant public health challenge, advancements in medications like Saxenda® and Wegovy® represent critical tools in the fight against this condition.


Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.

Medical Weight Management Training

Ready to Build a GLP-1 Weight Management Program?

Build the clinical, operational, and business foundations to evaluate GLP-1 weight-management services for your practice—without handing your patient relationships to a corporate intermediary.

Explore GLP-1 Certification Training →
✓Build direct patient relationshipsLearn a practice-centered approach to GLP-1 weight management and patient education.
✓Create a stronger program foundationExplore patient flow, clinical considerations, and practical service-development decisions.
✓Stay informed as the field evolvesBuild context for evidence, protocol, and regulatory considerations that affect medical weight management.
✓Bring business and clinical learning togetherLearn practice-building fundamentals alongside the clinical foundations for responsible growth.

Want to add Botox® training to your broader practice plan? Explore IAPAM’s Botox training options →

Ready to Transform Your Practice with GLP-1s?

Request your Quick Start Checklist for Starting or Integrating a New GLP-1 for Weight Loss Guide.

Request your free copy
Aesthetic Medicine + GLP-1 Training

Secure your seat at 50% off

Terms and conditions apply. Offer expires September 30.